OMRON Healthcare India announces strategic association with MMM
Hyderabad, 31st May 2022: OMRON Healthcare India, one of the leading players in the digital home blood pressure monitoring segment, today announced support towards the #THEBIGSQUEEZE movement to bolster the ongoing ‘May Measurement Month (MMM)’ global campaign in India.
This movement aims to encourage people of all ages to get their blood pressure checked in the world’s largest FREE blood pressure screening campaign. The...
India Exim Bank – JBIC conclude US$ 100 mn loan agreement
Export-Import Bank of India (India Exim Bank) concluded a USD 100 mn loan agreement with Japan Bank for International Cooperation (JBIC), along with three Japanese private financial institutions, namely, MUFG Bank, Ltd., the Bank of Kyoto, Ltd., and the Hachijuni Bank, Ltd., on May 23, 2022, on the side-lines of the Quad Leaders' Summit. The purpose of this facility...
Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’
National, 21 May 2022: - Regrow Biosciences, an Indian-centric global biotech company, is glad to announce a breakthrough achievement of getting a USFDA nod for conducting a phase II trial of its lead product 'OSSGROW,' an orphan drug that helps in effectively treating Osteonecrosis, in the US market. The accomplishment reflects the brand's commitment to delivering a safe, effective,...
Funds managed by MOPE invest in Pathkind Diagnostics
Mumbai, 20th May 2022: India Business Excellence Fund – IV, a fund managed and advised by MOPE (MO Alternate Investment Advisors Private Limited ), has agreed to make a primary investment of upto INR 194.4 crore (USD 25 million) in Pathkind Diagnostics Private Limited (“Pathkind”/ “Company”), a pathology focused diagnostics services chain with operations across 23 states in India.
Established in 2016, Pathkind is one of the fastest growing diagnostics services chain in India. It is promoted by Mr. Sanjeev Vashishta and the promoters of Mankind Pharma. Pathkind operates...
On World IBD Day, Janssen Launches icare4u Programme
Mumbai, Maharashtra, India...The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of icare4u, a comprehensive program to support the mental and physical health of millions of Indians affected by disorders caused by excessive inflammation.The innovative program is being launched at a critical time, with many Indians overwhelmed by the ongoing pandemic and finding it even harder...
JBCPL emerges as the fastest growing pharma company
New Delhi/Mumbai, May 11, 2022: Amid the ongoing COVID pandemic and the crisis created by it, (JBCPL) JB Chemicals & Pharmaceuticals Ltd., has emerged as the fastest growing pharmaceuticals company amongst the top 25 companies in the Indian Pharmaceutical Market during the Financial Year 2021-22 registering an impressive growth rate of 29% outperforming the market rate of 18% as per...
Nua partners with Deepika Padukone to transform menstrual wellness in India
Bengaluru, April 30th, 2022: Onto becoming every Indian woman’s menstrual health companion, leading Femtech brand Nua has announced TIME100 honouree, actor Deepika Padukone as the face of the brand for its Menstrual wellness products such as Sanitary Pads, Cramp Comfort, Intimate Wash and Panty Liners.
Being one of the top Femtech brands, Nua aims to help every Indian woman priorities their...
Astaberry expands its product range, ropes in Mouni Roy as Brand Ambassador
Mumbai/Delhi, 30th April 2022: Gurgaon-based company Ivia Beaute Pvt Ltd with their flagship brands ‘Astaberry’ and ‘Ikin’ recently launched their new product range of Hair Removal Creams and Wine Facial Kits. Inspired by Ayurveda and formulated with Science, the move is to create a one-stop solution for all personal care needs and also to expand their ever-growing cruelty free, vegan...
MEDIKABAZAAR joins hands with India Health Link
New Delhi, April 30, 2022: India’s largest B2B platform for medical supplies – MEDIKABAZAAR, join hands with India Health Link (IHL), a PHYGITAL health and medical device start-up, which has come up with first-of-its-kind human-centric preventive healthcare program that aims to bridge the primary healthcare gaps in India.
India Health Link (IHL) has introduced a first-of-its-kind connected ‘user centric’ and award-winning...
Glenmark becomes 1st pharma Company to launch FDC drug for type 2 diabetes in India
Mumbai, April 26, 2022: Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor),Teneligliptin, with Pioglitazone. This is the only available DPP4 and Glitazone combination brand in India for adults with uncontrolled Type 2 diabetes. Glenmark has launched this FDC under the brand...